3Kaisary AV.Intravesical BCG therapy in the management of multiple superficial bladder carcinoma:comparison between glaxo and pasteur strains.Br J Urol ,1987,59:554-558.
4Jurincic CD,Engelmann U,Gasch J,et al.Immunotherapy in bladder cancer with keyholelimpet hemocyamia;a randomized study.J Urol,1988,139:723-736.
5Brosman SA.Experience with superficial bladder carcinoma.J Urol,1982,128:27-30.
6Popert RJM,Goodall J,Coptcoat MJ,et al.Superficial bladder cancer:the response of a marker tumour to a single intravesical instillation of epirubicin.Br J Urol,1994,66:195-199.
7Oosterlinch W,Kurth KH,Schroder F,et al.A prospective European organization for research and treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single instillation of epirubicin or eater in single stage Ta,Ti papillary carcinoma of the bladder.J Urol,1993,149:749-752.
3Takayanagi A, Masumori N, Takahashi A, et al. Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors [J].Int J Urol, 2012, 19 (3) : 229 -233.
4Kong CZ. Pay attention to the study of bladder cancer recurrence [J].Zhonghua Yi Xue Za Zhi, 2010, 90 (18) : 1225 -1226.
5Dalbagni G. Bladder cancer: restaging tur reduces recurrence and pro- gression risk [J]. Nat Rev Urol, 2010, 7 (12) : 649 -650.
6Retz M, Lehmann J, Wullich B, et al. after - care of bladder carcino- ma [J]. Urologe A, 2001, 40 (6): 480-484.
